Showing results (81-90 of 13,220) with videos related to
Sort By:
Pageof 1,322
Journal of Psychiatric Research|January 1, 1989
A potential mechanism underlying the voluntary suppression of tardive dyskinesiaM P Caligiuri, J B LohrThe Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1990
Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the handM P Caligiuri, J B LohrBlood|December 18, 2004
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulationRossana Trotta, Robin Parihar, Jianhua Yu, et al.Breast Cancer Research and Treatment|December 4, 2008
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumabAruna Mani, Julie Roda, Donn Young, et al.The Journal of Clinical Investigation|March 1, 1997
A potential role for interleukin-15 in the regulation of human natural killer cell survivalW E Carson, T A Fehniger, S Haldar, et al.The Journal of Experimental Medicine|October 1, 1994
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptorW E Carson, J G Giri, M J Lindemann, et al.Forensic Science|March 1, 1976
The increasing use of paraquat as a suicidal agentD J Carson, E D CarsonCritical Reviews in Food Science and Nutrition|August 6, 2016
A review of the relative efficacy of dietary, nutritional supplements, lifestyle, and drug therapies in the management of hypertensionStephanie P B Caligiuri, Grant N PierceMondo Ortodontico|January 1, 1989
[Role of soft tissue in orthodontic diagnosis. 1]F M Caligiuri, C Malagola, E BarbatoJournal of Hematology & Oncology|March 22, 2022
A four-stage model for murine natural killer cell development in vivoShoubao Ma, Michael A Caligiuri, Jianhua YuPageof 1,322